Classification:
Title:
Ezetimibe
CAS NO.：
163222-33-1
Summary:
GMP
Description:
Ezetimibe is a lipid-lowering medication that works by selectively inhibiting the absorption of cholesterol in the small intestine. It is primarily used to reduce total cholesterol, LDL cholesterol, and triglycerides while increasing HDL cholesterol levels. Ezetimibe is often prescribed alone or in combination with statins for patients with hypercholesterolemia or cardiovascular risk. With excellent tolerability and minimal side effects, it provides an effective and safe treatment option for long-term cholesterol management.
Keywords:
Salcaprozate Sodium（SNAC）
Sodium Decanoate/Sodium Caprate（C10）
Potassium decanoate
N-(5-chlorosalicyloyl)-8-aminocaprylic acid（5-CNAC）（ 1:1 ）、（ 1:2 ）
10-(2-Hydroxybenzamido)decanoic acid (SNAD) (1:1) 、（1:2）
Sodium; 7-(2-hydroxy-benzoylamino)-heptanoate (SNAG)
Similar related products
The products supplied by the company are only used for research and development. Except for the approval of the competent authority, it is strictly prohibited to be used in the production and sales of medicines, food and health products.
NO.
Name
CAS
Abstract
More
